Luigi Mangione, the 28-year-old former Ivy Leaguer accused of assassinating UnitedHealthcare CEO Brian Thompson, returned to court on Monday for a hearing on jury selection in his upcoming federal trial. This comes after reports that a potential plea deal had fallen apart.
Background
Mangione is facing a separate state-level murder case in the December 2024 shooting of Thompson, 50. Since April, Justice Department prosecutors and Mangione’s defense team have been working on the jury questionnaire for his federal trial.
The proposed jury questionnaires have not been made public, but the sides have argued about them in court filings. Prosecutors filed a letter with the court in May listing their objections to some of the defense’s proposed questions, calling some overly intrusive or duplicative.
The defense is seeking to ask jurors about their living situations, employment status, faith, and background information on their children, among other things. They also want to know if a juror regularly stays at the Hilton on 6th Avenue, the scene of the crime, and whether the potential juror works for or holds stock in UnitedHealthcare.
Plea Deal
Last week, reports citing anonymous sources claimed that Mangione’s attorneys and federal prosecutors were having discussions about a plea deal but were unable to come to an agreement. Mangione’s lawyer, Karen Friedman Agnifilo, called the information attributed to anonymous sources a “troubling, deliberate pattern by prosecutors and law enforcement to prejudice Luigi.”
Original reporting: Fox News (HLL/CB) — read the source article.
